Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Ischemic Stroke
Recruiting
Phase 1 Results N/ASummary of Purpose
Stroke is a frequently occurring and common diseases in nervous system,and most of the survivors will remain disorders of motor,sensory and cognition function.Stem cell transplantation provides a promising approach for rehabilitation. The main objective of this study is to evaluate the efficacy and safy of the transplantation of autologous bone marrow mesenchymal stem cells in patients with chronic stroke.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 29 September 2015.
1 Nov 2014 | 29 Sep 2015 | 1 Nov 2016 | 1 Nov 2017 | 1 Sep 2015 | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Basics
Interventions
Conditions
Sponsors
Trial Design
- Allocation: Randomized
- Masking: Single Blind (Outcomes Assessor)
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
Contacts
- Xiaodan Jiang, MD,PhD
jiangxiao_dan@163.com 86 20 61643268
View Trial Locations
Recruitment
- Enrollment: 40
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 1 location, 1 country
Principal Investigator
- Xiaodan Jiang, MD,PhD
jiangxiao_dan@163.com 86 20 61643268